公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
公司地址 11570 6th Street, Rancho Cucamonga, CA, USA, 91730
電話號碼 +1 909 980-9484
傳真號碼 --
公司網頁 https://www.amphastar.com
員工數量 1976
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. William J. Peters Director, Chief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems Limited 美元 649.85K 13/04/2026
Dr. Jack Yongfeng Zhang, PhD Director, President, Chief Executive Officer and Chief Scientific Officer 美元 950.91K 13/04/2026
Dr. Mary Ziping Luo, PhD Chairman of the Board, Chief Operating Officer and Chief Scientist 美元 775.12K 13/04/2026
Mr. Rong Zhou Senior Executive Vice President, Production; President of Amphastar Nanjing Pharmaceuticals, Co., Ltd. 美元 717.59K 13/04/2026
Mr. Jacob Liawatidewi Executive Vice President, Sales and Marketing and Corporate Administration Center;President of Amphastar France Pharmaceuticals, S.A.S 美元 499.91K 13/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. Howard S. Lee, PhD Independent Director 13/04/2026
Mr. Richard Prins Lead Independent Director 13/04/2026
Mr. William J. Peters Director, Chief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems Limited 13/04/2026
Mr. David Gaugh Independent Director 13/04/2026
Dr. Jack Yongfeng Zhang, PhD Director, President, Chief Executive Officer and Chief Scientific Officer 13/04/2026
Dr. Mary Ziping Luo, PhD Chairman of the Board, Chief Operating Officer and Chief Scientist 13/04/2026
Dr. Michael A. Zasloff, M.D.,PhD Independent Director 13/04/2026
Mr. Floyd F. Petersen, M.P.H. Independent Director 13/04/2026
Ms. Diane G. Gerst Independent Director 13/04/2026
Mr. Jacob Liawatidewi Executive Vice President, Sales and Marketing and Corporate Administration Center;President of Amphastar France Pharmaceuticals, S.A.S 13/04/2026
Ms. Gayle M. Deflin Independent Director 13/04/2026
 
所屬ETF (更新日期: 02/05/2026 04:35)
代號 名稱 佔比% 持有日期
EBILongview Advantage ETF0.003%29/04/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.003%29/04/2026
GRPZInvesco S&P SmallCap 600 GARP ETF0.003%29/04/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.002%29/04/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.002%29/04/2026
AVTMAvantis Total Equity Markets ETF0.002%29/04/2026
QSMLWisdomTree U.S. Small Cap Quality Gr0.001%28/04/2026
AVUQAvantis U.S. Quality ETF0.001%29/04/2026
SAAProShares Ultra SmallCap6000.001%29/04/2026
EBITHarbor AlphaEdge Small Cap Earners ETF0.001%29/04/2026
ESIXState Street® SPDR® S&P SmCap 600 ESGETF0.001%29/04/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
SCOWPacer S&P SmCp 600 Qul FCF Aristcrts ETF0.0003%29/04/2026
RESMColumbia Research Enhanced Small Cap ETF0.0001%29/04/2026
HDGProShares Hedge Replication0.0001%29/04/2026
RBProshares Russell 2000 Dynamic BufferETF0.00002%29/04/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.00001%29/04/2026
ACSVAmerican Century Small Cp Val Insgts ETF<0.000001%06/01/2026
AIEQAI Powered Equity ETF<0.000001%24/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
  1    2    3    4   5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.